Abstract
CONTEXT: A biomarker for discriminating mechanisms of chemotherapy-induced thrombocytopenia (CIT) (i.e. increased platelet destruction and decreased platelet production) would be valuable in managing treatment.
OBJECTIVE: We explored the discriminating value of platelet size indices for this purpose in a population of adult oncology patients.
MATERIALS AND METHODS: Mean platelet volume (MPV) and platelet distribution width (PDW) were compared between patients with (i) thrombocytopenia possibly due to increased platelet destruction; (ii) thrombocytopenia possibly due to decreased platelet destruction; and (iii) no thrombocytopenia.
RESULTS AND CONCLUSIONS: We obtained negative results, suggesting that these indices are not useful for discriminating different CIT mechanisms.
| Original language | English |
|---|---|
| Pages (from-to) | 51-7 |
| Number of pages | 7 |
| Journal | Biomarkers |
| Volume | 16 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Feb-2011 |
| Externally published | Yes |
Keywords
- Adult
- Aged
- Antineoplastic Agents/adverse effects
- Biomarkers, Pharmacological/blood
- Blood Platelets/pathology
- Cell Size/drug effects
- Drug-Related Side Effects and Adverse Reactions
- Female
- Humans
- Male
- Middle Aged
- Neoplasms/drug therapy
- Platelet Count
- Retrospective Studies
- Thrombocytopenia/chemically induced